Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. SPCX
3. MU
4. ACN
5. IBM
6. SPY
7. TSLA
8. DPZ
9. NVDA
10. PRIM

Go back to Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results

Vir Biotechnology Inc. (VIR) Tops Q4 EPS by 88c

February 24, 2022 4:39 PM EST

Vir Biotechnology Inc. (NASDAQ: VIR) reported Q4 EPS of $3.92, $0.88 better than the analyst estimate of $3.04. Revenue for the quarter came in at $812.7 million versus the consensus estimate of $622.9 million.

As of December 31, 2021, excluding restricted cash, the Company had approximately $909.5 million in cash, cash equivalents,... More